DHR logo

Danaher Corp

DHR

Build a strategy around DHR

Accountable AI Logo

Danaher Corp AI Insights

Informational only. Not investment advice.
As of 2025-12-08

Snapshot

  • Goodwill of 42.9B is 84% of equity (51.1B) - tangible book value is NEGATIVE (-10B), creating material impairment risk[Goodwill]
  • Operating margin TTM 19% vs industry median 2% - 9.5x advantage from Danaher Business System driving pricing power[Operating Margin TTM]
  • FCF of 5B TTM (21% margin) with 2B buybacks - returning capital while maintaining 0.33 debt/equity[Free Cash Flow TTM]

Watch Triggers

  • ROIC TTM: Falls below 4%Would signal goodwill impairment risk and failed acquisition integration
  • Gross Margin TTM: Drops below 55%Indicates pricing power erosion or bioprocessing competition intensifying
  • Free Cash Flow TTM: Falls below 4BConstrains M&A capacity and buyback program sustainability

Bull Case

Premium profitability (19% op margin vs 2% median) with 60% gross margins creates durable moat - Danaher Business System enables consistent margin expansion through acquisitions

Operating Margin TTMGross Margin TTM

FCF conversion of 80% (5B FCF on 6.3B operating CF) funds M&A without leverage - debt/equity 0.33 leaves acquisition firepower

Free Cash Flow TTMDebt to Equity

Bear Case

P/E of 44x vs industry median 35x with negative tangible book value (-10B) - premium valuation assumes flawless execution on 43B goodwill

PE RatioTangible Book Value

Asset turnover 0.30x vs industry 0.79x reflects capital-heavy model - ROIC of 5.1% barely exceeds cost of capital

Asset Turnover TTMROIC TTM

Bull vs Bear Balance

AI-generated sentiment analysis based on fundamental metrics and market conditions.

BearBull
55%

Leverage DHR's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.

Take Me to The Editor

Forward Thesis

Bioprocessing recovery to drive mid-single-digit organic growth by 2026

1-3ymed
  • Destocking cycle ending at biopharma customers
  • R&D spend of 1.6B TTM sustaining innovation pipeline
  • Recurring consumables model rebuilding momentum
Gross margin 60% TTM supports pricingEBITDA 6.9B provides investment capacityNet margin 14% vs industry 0.1%

Valuation Context

Caveats

Public Strategies Rankings

See how Danaher Corp ranks across different investment strategies.

Leverage DHR's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.

Data Partners
Morningstar Logo

Fundamental company data provided by Morningstar, updated daily.

Accountable Finance, Inc. Disclaimer
accountable.finance is not operated by a broker or a dealer. Under no circumstances does any information posted on accountable.finance represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. In no event shall accountable.finance be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on accountable.finance, or relating to the use of, or inability to use, accountable.finance or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Stock quotes and fundamental company data provided by Morningstar, updated daily.

Accountable Logo
© 2026 Accountable Finance, Inc. All rights reserved.